MENU
NOV 07, 2017 8:00 AM PST

WEBINAR: The power of multiplexing and applications of the QuantiGene Plex Assay in oncology research and diagnostics

Sponsored by: Thermo Fisher Scientific
Speaker

Abstract

Cancer research diagnostic services in pathology laboratories worldwide have been negatively impacted by a lack of fresh-frozen tissue samples, the degradation of DNA and RNA in archival tissue, and tumor heterogeneity. To get accurate and reproducible gene expression and amplification results using archival material, a more robust and accurate test adapted to current clinical research workflows is needed.

Thermo Fisher Scientific, the world leader in serving science, has developed a comprehensive portfolio of Invitrogen™ immunoassays based on Luminex® xMAP® (multianalyte profiling) technology, a high-throughput solution enabling simultaneous detection and quantitation of multiple proteins. This efficient technology has proven to be invaluable for the comprehensive study of biological systems.

For the quantification of RNA in archival material, the Invitrogen™ QuantiGene™ Plex Assay is a fast and efficient multiplex solution using branched DNA (bDNA) technology on Luminex technology–based magnetic beads. Institutions, as well as professors like Godfrey Grech, have partnered with Thermo Fisher Scientific to apply this method, and have determined that it has a wide range of potential applications in the diagnosis of tumors and is adaptable to the current diagnostic research workflow.

Professor Grech will explain the main advantages of this method, including: (1) accurate, simultaneous detection of multiple targets simultaneously, enhancing accuracy and sensitivity while minimizing use of precious patient samples, (2) exclusion of subjectivity and ambiguous results originating from image-based measurements, and (3) elimination of requirements for highly specialized facilities and human resources.

This method has a wide range of possible applications, including tumor classification with diagnostic potential and measurement of biomarkers in liquid biopsies, enabling better patient management and disease monitoring. Quantitative measurement of biomarkers in archival material is also useful in oncology research with access to libraries of clinically annotated material—allowing for the validation of potential biomarkers and their correlation with clinical research outcomes using retrospective studies.  

In this webinar, we will cover the following topics:

  • The benefits of multiplexing and Luminex technologies
  • The use of QuantiGene Plex Assays to accurately measure RNA from archival tumor sections
  • How to achieve quantitative measurement of biomarkers and correlation with clinical outcomes in retrospective studies 
  • Q&A opportunities with the experts

Join us for this scientist-to-scientist presentation to share and discuss how this powerful immunoassay platform can help you meet your research goals faster.

 


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
MAY 18, 2021 8:00 AM PDT
C.E. CREDITS
MAY 18, 2021 8:00 AM PDT
Date: May 18, 2021 Time: 8:00am (PST) The global pandemic has caused an increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide qu...
NOV 07, 2017 8:00 AM PST

WEBINAR: The power of multiplexing and applications of the QuantiGene Plex Assay in oncology research and diagnostics

Sponsored by: Thermo Fisher Scientific

Specialty

Cancer Research

Molecular Biology

Biomarkers

Biotechnology

Molecular Diagnostics

Cell Biology

Immunology

Cancer Diagnostics

Clinical Diagnostics

Genetics

Cancer Therapeutics

Dna

Cell Culture

Gene Expression

Laboratory Testing

Geography

North America40%

Europe27%

Asia13%

South America13%

Africa2%

Oceania1%

Registration Source

Website Visitors95%

Client/Sponsor Promotions4%

Job Title

Research Scientist16%

Student14%

Scientist12%

Executive8%

Facility/Department Manager8%

Medical Doctor/Specialist7%

Educator/Faculty7%

Medical Laboratory Technician7%

Biologist4%

Post Doc4%

Lab Management4%

Marketing/Sales4%

Clinical Laboratory Scientist3%

Consultant1%

Chemist1%

Pathologist1%

Organization

Academic Institution13%

Biotech Company8%

Hospital6%

Clinical Laboratory5%

Life Science Company4%

Pharmaceutical Company3%

Research Institute3%

Government3%

Medical Center2%

Medical School2%

Ambulatory Care2%

Contract Research Organization (Cro)1%

Consultant1%

Distribution/sales1%

Other3%


Show Resources
Loading Comments...
Show Resources